This inventor holds 1 USPTO granted patent. Top assignee: Licentia, Ltd.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Urmas Arumäe: Innovator in Neurotrophic Factor Research
Introduction
Urmas Arumäe is a prominent inventor based in Espoo, Finland. He has made significant contributions to the field of neurobiology, particularly in the study of glial cell line-derived neurotrophic factor (GDNF) receptors. His work has implications for understanding neurotrophic factors and their role in neuronal health and disease.
Latest Patents
Urmas Arumäe holds a patent for "Assays using glial cell line-derived neurotrophic factor receptors." This patent discloses receptors for GDNF, their cellular expression, isolation, biochemical characterization, and sequences. Notably, c-RET is identified as one receptor for GDNF, along with additional novel receptors. The patent also includes the preparation of monoclonal antibodies directed against GDNF.
Career Highlights
Urmas Arumäe is associated with Licentia Ltd., where he continues to advance research in neurotrophic factors. His innovative work has garnered attention in the scientific community, contributing to a deeper understanding of neurobiology.
Collaborations
Some of his notable coworkers include Carlos F. Ibanez and Petro Suvanto. Their collaborative efforts have further enriched the research landscape in neurotrophic factor studies.
Conclusion
Urmas Arumäe's contributions to the field of neurobiology through his patent and collaborative work highlight his role as an influential inventor. His research continues to pave the way for advancements in understanding neurotrophic factors and their applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
